Market Performance
Bristol-Myers Squibb Company (NYSE:BMY) reached a new 52-week high of $65.14 during today's trading session.
The Healthcare stock has traded year-to-date and 0.4% over the past week. The previous 52-week high was $64.97.
52 week highNYSE:BMY
Bristol-Myers Squibb Company (BMY) Hits New 52-Week High of $65.14
Market Performance Bristol-Myers Squibb Company (NYSE:BMY) reached a new 52-week high of $65.14 during today's trading session. The Healthcare stock has traded year-to-date and…
Company Overview
Bristol-Myers Squibb Company has a market capitalization of $104.2B. The stock's 52-week low was $45.27.
Reaching a 52-week high often signals strong momentum and investor confidence in Bristol-Myers Squibb Company. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Bristol-Myers Squibb Company currently trades at $65.14, positioning the stock at the 100th percentile of its 52-week range ($45.27 — $64.97). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View BMY Stock Page
Frequently Asked Questions
What is causing BMY's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our BMY news page.
What is BMY's 52-week range?
See full price history and interactive charts on our BMY chart page.
